The Gabelli Healthcare & Wellness Trust (GRX) Stock Price, News & Analysis

Company Overview

The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. Closed-ended funds are similar to mutual funds in that they invest in a basket of stocks but differ in that there is a fixed number of shares and no new capital can be injected. The Gabelli Healthcare and Wellness Trust differs from an ETF in that it is actively and not passively managed. The fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc, and invests in the healthcare sector of the public equity markets worldwide.

The Gabelli Healthcare and Wellness Trust maintains a balanced portfolio of companies whose primary operationsare in the healthcare and wellness sector including food & beverage. The top 10 holdings accounted for less than 25% of the portfolio in Q3 2022 with individual holding sizes running from 2.1% to 3.2% for the #1 holding, CVS. Also in the top five are Cigna, Nestle, and Johnson & Johnson.

The Gabelli Health and Wellness Trust is not limited in size or scope of the underlying business so long as the investment is sound. The company invests in stocks of all market capitalizations and sector so long as the underlying business is health or wellness related.

The fund’s management is overseen by Mario J. Gabelli, Chairman and CEO of GAMCO Investors, Inc. He and his tema benchmarks the fund against the S&P 500 Index, the S&P 500 Consumer Staples Index, and S&P 500 Health Care Index in an effort to maintain the most reasonable comparisons. GAMCO was founded in 1976 and has since grown to be managed more than a dozen publicly traded funds. The Gabelli Healthcare & Wellness Trust was launched in February 2007.

Written by Jeffrey Neal Johnson

Key Stats

• Today's Range: $10.08 to $10.22
• 50-Day Range: $10.08 to $11.18
• 52-Week Range: $8.55 to $11.24
• Volume: 20,892 shs
• Average Volume: 31,912 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 5.93%
• Price Target: N/A
• Consensus Rating: N/A

GRX Stock Analysis - Frequently Asked Questions

How have GRX shares performed this year?

The Gabelli Healthcare & Wellness Trust's stock was trading at $9.33 at the beginning of the year. Since then, GRX stock has increased by 8.5% and is now trading at $10.12.
View the best growth stocks for 2024 here.

Who are The Gabelli Healthcare & Wellness Trust's major shareholders?

The Gabelli Healthcare & Wellness Trust's top institutional shareholders include Aviance Capital Partners LLC, Stephens Inc. AR, International Assets Investment Management LLC and Wealth Enhancement Advisory Services LLC. Insiders that own company stock include Saba Capital Management, LP, Mario J Gabelli, Jeffrey J Jonas Jr and John Chester Ball.
View institutional ownership trends.

How do I buy shares of The Gabelli Healthcare & Wellness Trust?

Shares of GRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of The Gabelli Healthcare & Wellness Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that The Gabelli Healthcare & Wellness Trust investors own include The Gabelli Equity Trust (GAB), Cisco Systems (CSCO), General Electric (GE), Altria Group (MO), Park City Group (PCYG), Pfizer (PFE) and AT&T (T).

Company Calendar

• Ex-Dividend for 9/23 Dividend: 9/16/2024
• Dividend Payable: 9/23/2024
• Today: 11/21/2024
• Ex-Dividend for 12/20 Dividend: 12/13/2024
• Dividend Payable: 12/20/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: Financial Services
• Current Symbol: NYSE:GRX
• CUSIP: N/A
• CIK: 1391437
• Web: www.gabelli.com
• Phone: 914-921-5000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $-4,735,232.00
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A